REG - Venture Life Group - UltraDEX update

Venture LifeAnnouncement

30/04/2018 07:05

2018-04-30T06:00:21.142Zreuters.comtag:reuters.com,2018-04-30:newsml_RSd4552Ma:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-04-30T06:00:21.142Z2018-04-30T06:00:21.142Z_UCDP:parsn_lse_10.54.132.131_1.2.37102:2019-05-31T06:00:21.142Z3RSd4552MaREG - Venture Life Group  - UltraDEX update Healthcare (TRBC level 1)Pharmaceuticals & Medical Research (TRBC level 2)LEGACY: Pharmaceuticals (TRBC level 3)LEGACY: Generic & Specialty Pharmaceuticals (TRBC)Pharmaceuticals (NEC) (TRBC level 5)Pharmaceuticals (TRBC level 4)Western EuropeUnited KingdomEuropeSuggested SourcesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesVenture Life Group PLC








RNS Number : 4552M
Venture Life Group PLC
30 April 2018
 

Venture Life Group plc
("Venture Life" or "the Company")
 
UltraDEX update
 
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market announces an update on the UltraDEX brand. The Company has extended its agreement with key French distributor La Brosse et Dupont SAS ("La Brosse") to include the UltraDEX Sensitive toothpaste. The launch will take place in H2 2018 and follows the successful launch of the original UltraDEX range in Q1 2018 in France.
 
Founded in 1932, La Brosse is a former subsidiary of LVMH Moet Hennessy Louis Vuitton S.E. It serves customers through large and medium commercial outlets throughout France, including Leclerc and Carrefour, and has market leading products within the oral healthcare space. Le Brosse launched the original UltraDEX range into the French market during March 2018 and is building up a presence in the grocery multiples.
 
UltraDEX was also partnered in Italy and the Nordics in 2017, and after delivery of product in Q4 2017, these partners have also launched UltraDEX into their respective markets during H1 2018. Both partners are building a presence for the mouthwash, toothpaste and spray products in pharmacies and dentists, and early indications are positive for the sell through.
 
Separately, the Company announces the launch of the new UltraDEX 'One GoÔ' range in all 797 of the Superdrug stores in the UK from June 2018. UltraDEX 'One Go' is another new innovative line extension from the Company, providing single use sachets of the UltraDEX mouthwash.
 
Jerry Randall, CEO of Venture Life commented: "The extension of this agreement with La Brosse is a real testament to the continued international success of UltraDEX, particularly at such an early stage in their launch of the UltraDEX range in France.  I am delighted with the continued commercial development of the UltraDEX brand both in the UK and internationally, and we look forward updating the market further throughout the rest of the year.  
 
"It's also great news that our new product, UltraDEX 'One Go', has been so quickly adopted by one of the leading pharmacy chains, Superdrug, demonstrating our ability to rapidly develop and launch innovative new products into the consumer self-care channel, and we are hopeful to extend its presence further.  Innovation is key to the growth of consumer brands, and Venture Life has the experience and capabilities to develop and commercialise such new products."
 
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

 
Enquiries
 



Venture Life Group PLC


+44 (0) 1344 578 004




Jerry Randall, Chief Executive Officer








Adrian Crockett, Chief Financial Officer
 








Northland Capital Partners Limited (Nominated Adviser and Joint Broker)


+44 (0) 20 3861 6625




Matthew Johnson/Edward Hutton (Corporate Finance)








Bob Pountney (Corporate Broking)


















Turner Pope Investments (TPI) Ltd (Joint Broker)


+44 (0) 20 3621 4120




Andy Thacker


















Walbrook PR


venturelife@walbrookpr.com or +44 (0) 20 7933 8780




Anna Dunphy/Paul McManus


+44 (0) 7876 741 001 / +44 (0) 7980 541 893








 
 
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLLFLESDIDFIT